Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
Lexicon Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: March 26, 2024
Lexicon Pharmaceuticals reported fiscal year 2023 executive compensation information on March 26, 2024.
In 2023, five executives at Lexicon Pharmaceuticals received on average a compensation package of $2.1M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Lexicon Pharmaceuticals
Lonnel Coats, Chief Executive Officer, received $4.1M in total, which decreased by 1% compared to 2022. 51% of Coats' compensation, or $2.1M, was in option awards. Coats also received $386K in bonus, $741K in salary, $878K in stock awards, as well as $15K in other compensation.
For fiscal year 2023, the median employee pay was $206,303 at Lexicon Pharmaceuticals. Therefore, the ratio of Lonnel Coats' pay to the median employee pay was 20 to one.
Jeffrey L. Wade, Chief Financial Officer, received a compensation package of $2M, which decreased by 1% compared to previous year. 43% of the compensation package, or $853K, was in option awards.
Craig B. Granowitz, Chief Medical Officer, earned $1.5M in 2023, a 2% decrease compared to previous year.
Brian T. Crum, General Counsel, received $1.4M in 2023, which decreases by 2% compared to 2022.
Alan J. Main, Executive Vice President, Innovation and Chemical Sciences, earned $1.4M in 2023, a 2% decrease compared to previous year.
Related executives
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
Brian Crum
Lexicon Pharmaceuticals
General Counsel
Craig Granowitz
Lexicon Pharmaceuticals
Chief Medical Officer
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
You may also like
Source: SEC filing on March 26, 2024.